(14C)Methylphenidate hydrochloride. Studies on disposition in rat brain

Area of Science:

• Pharmacology
• Neuroscience
• Radiochemistry

Background:

• Methylphenidate is a central nervous system stimulant.
• Understanding its brain uptake and distribution is crucial for therapeutic applications.

Purpose of the Study:

• To compare the brain uptake and distribution of [14C]methylphenidate-HCl following intravenous (IV) and intraperitoneal (IP) administration in rats.
• To investigate the regional distribution and metabolic profile of methylphenidate in the brain.

Main Methods:

• Rats were administered [14C]methylphenidate-HCl via IV or IP routes.
• Plasma, brain, and specific brain regions were analyzed for total radioactivity and parent drug concentrations up to 6 hours post-dose.
• The distribution of [14C]ritalinic acid, a major metabolite, was also assessed after IV injection.

Main Results:

• IV administration resulted in 3- to 6-fold higher initial brain concentrations of methylphenidate compared to IP.
• After 30 minutes, brain and plasma concentrations became comparable between routes, with brain drug decline paralleling plasma decline.
• Predominantly unchanged methylphenidate was found in the brain, while metabolites dominated plasma concentrations.
• No significant regional variance in brain drug distribution was observed.
• The major metabolite, [14C]ritalinic acid, did not accumulate in brain tissue.

Conclusions:

• The route of administration significantly impacts the initial rate of methylphenidate brain entry.
• The brain retains methylphenidate primarily as the unchanged parent drug, irrespective of administration route.
• Metabolites of methylphenidate do not appear to significantly penetrate the brain parenchyma.